TITLE

Primer ve Nüks Pterjium Patogenezinde Mast Hücrelerinin Rolü

AUTHOR(S)
Deveci, Hülya; Yücetürk, Ayla; Yardım, Bengü Günay; Aydın, Saime
PUB. DATE
June 2012
SOURCE
Turkish Journal of Ophthalmology / Turk Oftalmoloji Dergisi;Jun2012, Vol. 42 Issue 3, p183
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Purpose: In this study, we aimed to investigate the roles of mast cells in pterygium pathogenesis and to compare the number of mast cells in primary and recurrent pterygium. Material and Method: In this study, we evaluated 49 eyes of 49 outpatients with pterygium and the 2 eyes of 1 outpatient with pterygium. Twenty-eight of pterygium tissues were primary type and twenty-three of them were recurrent type. Normal conjunctival tissues in the upper temporal quadrant of same eyes were included in the control group. The numbers of mast cells in the tissues of primary pterygium group, recurrent pterygium group and control group were compared. Results: The mean mast cell number in the pterygium tissues (8.9±6.5) was statistically significantly higher than the mean mast cell number in the control tissues (6.0±4.7) (p=0.000). Even though the mean mast cell number in the recurrent pterygium tissues (9.3±7.4) was higher than that in the primary pterygium tissues (8.5±5.3), the difference was not statistically significant (p=0.68). Discussion: These results suggest that mast cells play an important role in pterygium pathogenesis; however, more studies are necessary to demonstrate the difference between primary pterygium and recurrent pterygium.
ACCESSION #
76531416

 

Related Articles

  • Mast cell repopulation of the peritoneal cavity: contribution of mast cell progenitors versus bone marrow derived committed mast cell precursors. Jamur, Maria Célia; Moreno, Andréa N.; Mello, Luciana F. C.; Souza, Júnior, Devandir A.; Campos, Maria Rita C.; Pastor, Maria Verônica D.; Grodzki, Ana Cristina G.; Silva, Deise C.; Oliver, Constance // BMC Immunology;2010, Vol. 11, p32 

    Background: Mast cells have recently gained new importance as immunoregulatory cells that are involved in numerous pathological processes. One result of these processes is an increase in mast cell numbers at peripheral sites. This study was undertaken to determine the mast cell response in the...

  • Surgical method sets higher standard for managing pterygium. Agarwal, Amar // Ocular Surgery News;8/10/2008, Vol. 26 Issue 15, p45 

    The article discusses the management of pterygium. Surgeries for pterygium, one of the oldest pathologies known to ophthalmologists, can range from simple excision to techniques with exotic detail and meticulous maneuvers. The basis for the surgical steps involves a lamellar approach along with...

  • Is pterygia rare in young patients? Fraser, Scott // Pulse;7/26/2004, Vol. 64 Issue 30, p52 

    Discusses the reason for the occurrence of ptyregia in young patients. Description of pterygium; Factor for the development of the eye disease; Symptomatology of the disease.

  • Mast cells: Distal signalling in mast cell degranulation. Papatriantafyllou, Maria // Nature Reviews Immunology;Jun2013, Vol. 13 Issue 6, p393 

    The article reports on the findings of the study that determines the role of truncated splice variant of the FcƐRI ß-subunit in mast cell degranulation.

  • Mast cells in the human dura: effects of age and dural bleeding. Greeley, Christopher; Karst, Wouter // Child's Nervous System;Nov2013, Vol. 29 Issue 11, p1967 

    A letter to the editor is presented in response to the article "Mast cells in the human dura: effects of age and dural bleeding" by A. Varatharaj and colleagues in the September 7, 2013 issue.

  • Corneoscleral Perforation After Pterygium Excision and Intraoperative Mitomycin C. Dadeya, Subhash; Fatima, Shibal // Ophthalmic Surgery, Lasers & Imaging;Mar/Apr2003, Vol. 34 Issue 2, p146 

    A 28-year-old man underwent pterygium excision with a single intraoperative application of mitomycin C (0.02%) for 3 minutes. One week after the surgery, the patient developed a corneoscleral perforation with iris prolapse. To the best of our knowledge, corneoscleral melting in the first...

  • Become familiar with advances in pterygium surgery. Skorkin Jr., Leonid // Primary Care Optometry News;Jan2009, Vol. 14 Issue 1, p14 

    The article presents information on pterygium surgery. The goal of the surgery is to remove the pterygium with minimal surgical trauma to the globe and to prevent recurrence. It cites the symptoms which signify that pterygium surgery is needed. The newer modalities of the surgery, including...

  • Vertical Conjunctival Bridge Flaps in Pterygium Surgery. Kaya, Murat // Ophthalmic Surgery, Lasers & Imaging;Jul/Aug2003, Vol. 34 Issue 4, p279 

    BACKGROUND AND OBJECTIVE: To evaluate the recurrence rates and clinical outcome following pterygium surgery using a vertical conjunctival bridge flap technique. PATIENTS AND METHODS: The study included 500 patients operated on for primary or recurrent pterygium during 6 years (between 1994 and...

  • Pterygium. Solomon, A. S. // British Journal of Ophthalmology;Jun2006, Vol. 90 Issue 6, p665 

    The article comments on several studies about pterygium. Pterygium is a frequently occurring lesion in the eyes characterized by inflammation, angiogenesis and cellular proliferation, resulting in tissue remodeling. Wong and colleagues examine a new gene that was changed in primary pterygium....

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics